Opal Healthcare Limited

Manufacturing and distribution of Generic Hospital Injecatble products.
Wholesale and distribution of Ethical Pharmaceutical products
Development and co-operation with UK Universities of new chemical entities for the oncology market.

Activity:

- Licensing & Business Development
- Manufacturing
- Market Research & Marketing
- Research & Development
- Sales & Distribution

Product / Technology type(s) covered:

- Bio
- Generics
- FP (finished products)
- Pharmaceuticals / Therapeutics
- Prescription drugs (Rx)

Therapeutic targets:

- AIDS
- Cancer
- Cardiovascular
- Epidemiology
- Gastrointestinal
- Genetics
- Geriatrics
- Infectious Diseases
- Mental Health
- Neurology
- Oncology
- Pain
- Stroke
- Surgery

Markets Covered

a. HeadQuarter: United Kingdom

b. Continent(s) active: Africa , Europe , Near/Middle East , North America

c. Countries active: UK, Germany, France, Italy, Spain, Greece, Ireland, Oman, UAE

Corporate data:

Number of Employees: 12

Turnover:

Amount:	Year:	Currency:
5.234.000	2002	Euro

Year founded: 2002

Partners / Alliances: PSI (Belgium)
Oncogen (Europe)
Opal Healthcare Oman Ltd
Opal Generics Limited
Opal Biosciences Limited